Onychocryptosis as consequence of effective treatment of dermatophytic onychomycosis [14]

Journal of the European Academy of Dermatology and Venereology

Volumn 21, Issue 5, 2007, Pages 699-700

  Bonifaz, A ^a,b   Paredes, V ^a   Fierro, L ^a  

^a HOSPITAL GENERAL DE MÉXICO   (Mexico)

^b NONE   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; ITRACONAZOLE; TERBINAFINE;

DRUG EFFICACY; DRUG PULSE THERAPY; FUNGUS CULTURE; HUMAN; LETTER; MAJOR CLINICAL STUDY; NAIL DISEASE; NAIL DYSTROPHY; NONHUMAN; ONYCHOCRYPTOSIS; ONYCHOMYCOSIS; PARONYCHIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TRICHOPHYTON MENTAGROPHYTES; TRICHOPHYTON RUBRUM;

ADMINISTRATION, ORAL; ANTIFUNGAL AGENTS; DRUG THERAPY, COMBINATION; FLUCONAZOLE; HUMANS; ITRACONAZOLE; NAILS, INGROWN; NAPHTHALENES; ONYCHOMYCOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 34250348025     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2006.01994.x     Document Type: Letter

References (8)

1. Baran R, Gupta AK, Pierard GE. Pharmacotherapy of onychomycosis. Expert Opin Pharmacother 2005; 4: 609-624.
2. Connelley LK Jr, Dinerhart SM, McDonald R. Onychocryptosis associated with the treatment of onychomycosis. J Am Podiatr Med Assoc 1999; 89: 424-426.
3. Weaver TD, Jespersen DL. Multiple onychocryptosis following treatment of onychomycosis with oral terbinafine. Cutis 2000; 66: 211-212.
4. DeLauro NM, DeLauro TM. Onychocryptosis. Clin Podiatr Med Surg 2004; 21: 617-630.
5. Langford DT, Burke C, Robertson K. Risk factors in onychocryptosis. Br J Surg 1989; 76: 45-48.
6. Ikard RW. Onychocryptosis. J Am Coll Surg 1989; 187: 96-102.
7. Robbins JM. Treatment of onychomycosis in the diabetic patient population. J Diabetes Complications 2003; 17: 98-104.
8. Robbins JM. Recognizing, treating, and preventing common foot problems. Cleve Clin J Med 2000; 67: 45-56.